Request Deal Involvement

CTI Life Sciences led a $115m Series C round in Glycomine.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Little Dog Communications

pr advisors

Little Dog Communications

H/Advisors Abernathy

pr advisors

H/Advisors Abernathy

or

Principals

SANOFI VENTURES

bidder

SANOFI VENTURES

SANDERLING VENTURES

bidder

SANDERLING VENTURES

ABINGWORTH MANAGEMENT

bidder

ABINGWORTH MANAGEMENT

GLYCOMINE INC

target

GLYCOMINE INC

CTI LIFE SCIENCES FUND

bidder

CTI LIFE SCIENCES FUND

REMIGES VENTURES

bidder

REMIGES VENTURES

NOVO HOLDINGS A/S

bidder

NOVO HOLDINGS A/S

RIVERVEST VENTURE PARTNERS

bidder

RIVERVEST VENTURE PARTNERS

CHIESI VENTURES

bidder

CHIESI VENTURES

ASAHI KASEI VENTURES

bidder

ASAHI KASEI VENTURES

ADVENT LIFE SCIENCES

bidder

ADVENT LIFE SCIENCES

ABRDN INC

bidder

ABRDN INC

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - CTI Life Sciences led a $115m Series C round in Glycomine.